Clinical coordinating center for nida's clinical trials network. Contract type: IDIQ task order. POP: 8/15/24 - 8/14/29
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95024D00037
- Awardee
-
The Emmes Company, LLC UEI NBQCBJ6FXBU4
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 6 $23,166,259 obligated
Award facts
- Opportunity
-
- Clinical Coordinating Center for NIDA’s Clinical Trials Network Pre-Solicitation · 75N95024R00025 · Posted Aug 17, 2023
- Combined order value
- $23,166,259 Current and potential, with all options
- Last date to order 44% complete
- IDV ceiling 47% used
- $49,500,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 3 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
- Legislative mandates
-
- Service Contract Act FAR subpart 22.10
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The National Institute on Drug Abuse awarded an indefinite-delivery contract to The Emmes Company, LLC for $49.5 million on August 15, 2024, as a single-award vehicle. The contract funds clinical coordinating center operations for NIDA's Clinical Trials Network through August 14, 2029.
Place of performance is Rockville, Maryland. The originating solicitation, posted August 17, 2023, sought a clinical coordinating center to coordinate multi-site clinical trials and support data coordinating center functions for NIDA's substance abuse treatment research, including studies on opioid use disorder, stimulant use, cocaine use, and related conditions.
The contract is structured as cost-plus-fixed-fee delivery orders. Six task orders have been issued under this IDIQ: Task Order 1 (CTN Portfolio Support, non-HEAL phase, $4,115,202, ultimate completion August 14, 2025); Task Order 2 (CTN HEAL Enhancement, $2,988,430, ultimate completion November 1, 2026); a clinical coordinating center order for CTN Study CTN-0100 (Optimizing Retention, Duration and Discontinuation Strategies for Opioid Use Disorder Pharmacotherapy, $3,944,274, ultimate completion April 2, 2028); Task Order 4 ($4,656,081.38, ultimate completion July 15, 2026); Task Order 5 ($2,501,452.23, ultimate completion March 31, 2028); and Task Order 6 ($4,960,819.41, ultimate completion August 14, 2029). All task orders are placed at Rockville, Maryland, and Emmes self-performs the work with no reported subcontractors.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract 75N95024D00037?
75N95024D00037 was awarded to The Emmes Company, LLC by National Institute on Drug Abuse (National Institutes of Health) on August 15, 2024.
How much is contract 75N95024D00037 worth?
Orders under 75N95024D00037 have obligated $23,166,259. 75N95024D00037's own ceiling is $49,500,000.
How many orders have been placed under contract 75N95024D00037?
6 orders have been placed under 75N95024D00037, the latest on July 16, 2025.
Who can order from contract 75N95024D00037?
75N95024D00037 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95024D00037 competed?
The extent of competition for 75N95024D00037 was full and open competition. The government received 3 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV